Please login to the form below

Not currently logged in
Email:
Password:

Vectura's mystery partner licenses asthma drug for EUR 15.5m

Vectura says it could win up to EUR 15.5m after signing a licensing agreement with an unnamed international pharmaceutical company regarding its combination asthma treatment VR632

UK-based inhaleable drug company Vectura has revealed it could win up to EUR 15.5m in milestone payments, development funding and post-launch royalties after signing a licensing agreement with an unnamed international pharmaceutical company regarding its combination asthma treatment VR632.

The company, with which Vectura already has an agreement regarding its other asthma treatment VR315, will be responsible for the clinical development, manufacture and EU marketing of VR632, with Vectura having access to all clinical data generated from the collaboration.

The molecule will be developed for use with Vectura's GyroHaler inhaler device, and under the deal Vectura will be responsible for the supply of the device, along with further formulation development of VR632.

Vectura's CEO, Chris Blackwell, said: "It is a major extension to one of the three key licensing deals we have concluded for products delivered using GyroHaler and is the second announcement relating to this technology in as many months. It is also further endorsement of the added value Vectura can deliver in respiratory product development."

3rd December 2007

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....